Revenue from Contracts with Customers (Tables)

12 Months Ended

Dec. 29, 2023

Revenue from Contract with Customer [Abstract]

Product sales transferred to customers at a point in time and over time were as follows:


	Successor		Predecessor
	Period from November 15, 2023 through December 29, 2023		Period from December 31, 2022 through November 14, 2023		Period from June 17, 2022 through December 30, 2022		Period from January 1, 2022 through June 16, 2022		Year Ended December 31, 2021
Product sales transferred at a point in time	85.3	%	83.2	%	83.0	%	80.8	%	79.4	%
Product sales transferred over time	14.7		16.8		17.0		19.2		20.6

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction

Transaction price allocated to the remaining performance obligations

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of December 29, 2023 (Successor):


Fiscal 2024 (1)	$	41.6
Fiscal 2025 (1)	23.7
Thereafter	4.2

Disaggregation of Revenue - Royalty

The associated royalty revenue recognized was as follows:


	Successor		Predecessor
	Period from November 15, 2023 through December 29, 2023		Period from December 31, 2022 through November 14, 2023		Period from June 17, 2022 through December 30, 2022		Period from January 1, 2022 through June 16, 2022		Year Ended December 31, 2021
Royalty revenue	$	0.1	$	4.3	$	36.2	$	34.9	$	102.4

Sales Reserve Rollforward

The following table reflects activity in the Company's sales reserve accounts:


	Rebates and Chargebacks (1)		Product Returns		Other Sales Deductions		Total
Balance as of December 25, 2020 (Predecessor)	196.5		26.6		12.3		235.4
Provisions	2,087.1		23.7		55.2		2,166.0
Payments or credits	(2,041.8)		(28.8)		(58.0)		(2,128.6)
Balance as of December 31, 2021 (Predecessor)	241.8		21.5		9.5		272.8
Provisions	693.4		5.2		17.1		715.7
Payments or credits	(684.6)		(8.1)		(18.9)		(711.6)
Balance as of June 16, 2022 (Predecessor)	$	250.6	$	18.6	$	7.7	$	276.9


Balance as of June 17, 2022 (Predecessor)	$	250.6	$	18.6	$	7.7	$	276.9
Provisions	804.4		7.0		36.7		848.1
Payments or credits	(789.7)		(9.6)		(31.7)		(831.0)
Balance as of December 30, 2022 (Predecessor)	$	265.3	$	16.0	$	12.7	$	294.0
Provisions	1,368.8		9.9		43.3		1,422.0
Payments or credits	(1,410.1)		(13.1)		(42.3)		(1,465.5)
Balance as of November 14, 2023 (Predecessor)	$	224.0	$	12.8	$	13.7	$	250.5


Balance as of November 15, 2023 (Successor)	$	224.0	$	12.8	$	13.7	$	250.5
Provisions	173.0		3.0		6.9		182.9
Payments or credits	(195.4)		(1.3)		(9.3)		(206.0)
Balance as of December 29, 2023 (Successor)	$	201.6	$	14.5	$	11.3	$	227.4

(1)Includes $59.0 million and $89.3 million of accrued Medicaid and $35.1 million and $55.3 million of accrued rebates as of December 29, 2023 (Successor) and December 30, 2022 (Predecessor), respectively, included within accrued and other current liabilities in the consolidated balance sheets.